Thrivent Financial for Lutherans’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $33.9M | Sell |
75,977
-710
| -0.9% | -$331K | 0.06% | 329 |
|
|
2025
Q4 | $34.8M | Sell |
76,687
-1,583
| -2% | -$682K | 0.06% | 339 |
|
|
2025
Q3 | $30.7M | Sell |
78,270
-9,932
| -11% | -$4.15M | 0.06% | 325 |
|
|
2025
Q2 | $39.3M | Buy |
88,202
+1,119
| +1% | +$516K | 0.09% | 269 |
|
|
2025
Q1 | $42.2M | Sell |
87,083
-817
| -0.9% | -$381K | 0.09% | 274 |
|
|
2024
Q4 | $35.6M | Sell |
87,900
-3,775
| -4% | -$1.75M | 0.07% | 332 |
|
|
2024
Q3 | $42.6M | Sell |
91,675
-3,119
| -3% | -$1.5M | 0.08% | 305 |
|
|
2024
Q2 | $44.4M | Buy |
94,794
+5,827
| +7% | +$2.53M | 0.09% | 280 |
|
|
2024
Q1 | $37.2M | Buy |
88,967
+27,602
| +45% | +$11.7M | 0.07% | 308 |
|
|
2023
Q4 | $25M | Sell |
61,365
-14,266
| -19% | -$5.27M | 0.05% | 383 |
|
|
2023
Q3 | $26.3M | Sell |
75,631
-27,585
| -27% | -$9.65M | 0.06% | 343 |
|
|
2023
Q2 | $36.3M | Buy |
103,216
+30,041
| +41% | +$10.1M | 0.08% | 298 |
|
|
2023
Q1 | $23.1M | Sell |
73,175
-22,002
| -23% | -$6.6M | 0.06% | 386 |
|
|
2022
Q4 | $27.5M | Sell |
95,177
-137
| -0.1% | -$41.8K | 0.07% | 340 |
|
|
2022
Q3 | $27.6M | Sell |
95,314
-8,259
| -8% | -$2.38M | 0.08% | 312 |
|
|
2022
Q2 | $29.2M | Sell |
103,573
-1,299
| -1% | -$348K | 0.08% | 305 |
|
|
2022
Q1 | $27.4M | Buy |
104,872
+52,466
| +100% | +$12.5M | 0.05% | 369 |
|
|
2021
Q4 | $11.5M | Buy |
52,406
+8,056
| +18% | +$1.57M | 0.02% | 633 |
|
|
2021
Q3 | $8.04M | Sell |
44,350
-1
| -0% | -$195 | 0.02% | 741 |
|
|
2021
Q2 | $8.94M | Sell |
44,351
-63
| -0.1% | -$13.2K | 0.02% | 721 |
|
|
2021
Q1 | $9.54M | Sell |
44,414
-376,418
| -89% | -$82.7M | 0.02% | 673 |
|
|
2020
Q4 | $99.5M | Buy |
420,832
+23,679
| +6% | +$5.43M | 0.23% | 107 |
|
|
2020
Q3 | $108M | Sell |
397,153
-36,689
| -8% | -$10.1M | 0.29% | 73 |
|
|
2020
Q2 | $126M | Sell |
433,842
-55,136
| -11% | -$14.9M | 0.38% | 48 |
|
|
2020
Q1 | $116M | Sell |
488,978
-24,803
| -5% | -$5.69M | 0.42% | 40 |
|
|
2019
Q4 | $112M | Sell |
513,781
-10,372
| -2% | -$2.1M | 0.32% | 66 |
|
|
2019
Q3 | $88.8M | Buy |
524,153
+36,176
| +7% | +$6.4M | 0.28% | 91 |
|
|
2019
Q2 | $89.5M | Sell |
487,977
-95,109
| -16% | -$16.6M | 0.27% | 82 |
|
|
2019
Q1 | $107M | Sell |
583,086
-18,473
| -3% | -$3.41M | 0.34% | 62 |
|
|
2018
Q4 | $99.7M | Buy |
601,559
+257,683
| +75% | +$44.6M | 0.36% | 56 |
|
|
2018
Q3 | $66.3M | Sell |
343,876
-13,870
| -4% | -$2.47M | 0.21% | 118 |
|
|
2018
Q2 | $60.8M | Buy |
357,746
+261,618
| +272% | +$40.6M | 0.2% | 122 |
|
|
2018
Q1 | $15.7M | Sell |
96,128
-7,010
| -7% | -$1.15M | 0.05% | 349 |
|
|
2017
Q4 | $15.5M | Buy |
103,138
+4,844
| +5% | +$717K | 0.05% | 344 |
|
|
2017
Q3 | $14.9M | Buy |
98,294
+630
| +0.6% | +$94.8K | 0.05% | 320 |
|
|
2017
Q2 | $12.6M | Sell |
97,664
-9,950
| -9% | -$1.2M | 0.05% | 331 |
|
|
2017
Q1 | $11.8M | Sell |
107,614
-825,878
| -88% | -$72.7M | 0.05% | 341 |
|
|
2016
Q4 | $68.8M | Sell |
933,492
-220,481
| -19% | -$17.9M | 0.31% | 84 |
|
|
2016
Q3 | $101M | Buy |
1,153,973
+49,570
| +4% | +$4.68M | 0.46% | 45 |
|
|
2016
Q2 | $95M | Buy |
1,104,403
+96,671
| +10% | +$8.35M | 0.45% | 46 |
|
|
2016
Q1 | $80.1M | Sell |
1,007,732
-47,360
| -4% | -$4.28M | 0.39% | 57 |
|
|
2015
Q4 | $133M | Buy |
1,055,092
+30,780
| +3% | +$3.72M | 0.64% | 38 |
|
|
2015
Q3 | $107M | Buy |
1,024,312
+265,282
| +35% | +$34.1M | 0.56% | 39 |
|
|
2015
Q2 | $93.7M | Sell |
759,030
-153,130
| -17% | -$19.3M | 0.52% | 44 |
|
|
2015
Q1 | $108M | Sell |
912,160
-276,091
| -23% | -$33.1M | 0.6% | 36 |
|
|
2014
Q4 | $141M | Buy |
1,188,251
+90,162
| +8% | +$10.2M | 0.78% | 25 |
|
|
2014
Q3 | $123M | Buy |
1,098,089
+1,069,239
| +3,706% | +$102M | 0.71% | 32 |
|
|
2014
Q2 | $2.73M | Sell |
28,850
-44,350
| -61% | -$3.11M | 0.02% | 635 |
|
|
2014
Q1 | $5.18M | Buy |
73,200
+67,700
| +1,231% | +$5.36M | 0.03% | 434 |
|
|
2013
Q4 | $409K | Hold |
5,500
| – | – | ﹤0.01% | 1082 |
|
|
2013
Q3 | $417K | Sell |
5,500
-399,320
| -99% | -$31.8M | ﹤0.01% | 1024 |
|
|
2013
Q2 | $32.4K | Buy |
+404,820
| New | +$29.8M | 0.21% | 109 |
|
Other funds holding VRTX
VCM
VPM
Thrivent Financial for Lutherans's VRTX Position: Q1 2026 in Review
Thrivent Financial for Lutherans reduced its Vertex Pharmaceuticals (VRTX) stake by 0.93% in Q1 2026, selling an estimated $331K and leaving 75,977 shares worth $33.9M. The position accounts for 0.06% of the portfolio, ranked #329.
Thrivent Financial for Lutherans first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $141M in Q4 2014. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Thrivent Financial for Lutherans held 75,977 shares of Vertex Pharmaceuticals worth $33.9M as of Q1 2026.
- Thrivent Financial for Lutherans sold 710 Vertex Pharmaceuticals shares in Q1 2026, an estimated $331K.
- Vertex Pharmaceuticals made up 0.06% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #329 holding.
- Thrivent Financial for Lutherans first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Thrivent Financial for Lutherans's Vertex Pharmaceuticals position peaked at $141M in Q4 2014.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.